Hydrochlorothiazide
Product Images NDC 10544-198

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 10544-198). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

25mg 30ct (Label Hydrochlorothiazide Tabs 25mg Bpi(10544 198 90) Lannett(0527 1413 10) Rev0)

Label for Hydrochlorothiazide Tablets USP 25 mg by Blenheim Pharmacal, Inc. The label shows a package of 30 tablets with NDC 10544-198-30. It includes storage instructions to keep the product at 20°-25°C (68°-77°F) and to store in a tight, light-resistant container. The label also states Rx only and advises to see package insert for dosage.*

FDA Label Image

Structure (Hydrochlorothiazide Capsule 1)

Chemical structure of Hydrochlorothiazide showing a benzothiadiazine ring with sulfonamide and chlorine substituents, labeled clearly in black lines, used in the active pharmaceutical ingredient identification for Blenheim Pharmacal, Inc. product NDC 10544-198.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.